Therefore, to provide proof of principle that the PD-1/PD-L1 blockade is effective against cancer, efforts were made to develop PD-1 inhibitors (anti-PD-1 or anti-PD-L1 antibody) for the treatment of human cancers (Fig. 1). The gene discussed is CD274; the disease is cancer.